COM:INOZYME

Inozyme

Stock

USD

Last Close

4.00

30/06 22:06

Market Cap

285.77M

Beta: -

Volume Today

462.93K

Avg: -

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
average inventory			-6.18M -	-6.21M 0.50%	-88.50K 98.57%	-57.50K 35.03%
average payables		942.50K -	1.99M 110.61%	2.73M 37.61%	2.47M 9.61%	1.85M 24.87%
average receivables		67.50K -	129.50K 91.85%	108.50K 16.22%	88.50K 18.43%	57.50K 35.03%
book value per share	-0.92 -	-2.19 139.07%	14.33 753.71%	4.64 67.62%	3.14 32.29%	0.00 99.91%
capex per share	-0.02 -	-0.01 46.41%	-0.05 461.28%	-0.02 67.26%	-0.01 35.57%	-0.00 99.95%
capex to depreciation	-9.96 -	-1.67 83.19%	-2.62 56.30%	-0.59 77.50%	-0.55 6.44%	0.06 111.74%
capex to operating cash flow	0.03 -	0.01 73.07%	0.02 113.67%	0.01 47.78%	0.01 13.90%	0.00 40.60%
capex to revenue
cash per share	2.85 -	3.11 9.04%	25.33 714.69%	4.75 81.26%	3.39 28.65%	0.00 99.89%
days of inventory on hand
days payables outstanding
days sales outstanding
debt to assets				0.03 -	0.05 78.46%	0.23 376.40%
debt to equity				0.03 -	0.06 85.25%	0.33 480.32%
dividend yield
earnings yield	-0.03 -	-0.07 166.95%	-0.25 250.07%	-0.35 43.24%	-1.65 370.09%	-0.00 99.98%
enterprise value	229.54M -	234.29M 2.07%	67.90M 71.02%	140.72M 107.26%	13.51M 90.40%	220.85B 1,634,067.29%
enterprise value over ebitda	-19.84 -	-11.31 43.03%	-1.19 89.47%	-2.51 111.22%	-0.20 92.17%	-2.92K 1,483,493.61%
ev to operating cash flow	-24.32 -	-12.46 48.79%	-1.89 84.85%	-2.92 54.84%	-0.23 91.99%	-3.12K 1,335,466.14%
ev to sales
free cash flow per share	-0.64 -	-1.25 95.14%	-3.31 164.88%	-2.06 37.76%	-1.54 25.25%	-0.00 99.91%
free cash flow yield	-0.04 -	-0.07 95.14%	-0.16 125.10%	-0.30 88.37%	-1.47 385.50%	-0.00 99.98%
graham net net	-0.94 -	-2.24 138.22%	23.76 1,160.85%	4.14 82.57%	2.84 31.51%	0.00 99.91%
graham number	3.08 -	7.78 152.63%	40.38 418.93%	15.81 60.85%	11.07 30.00%	0.01 99.92%
income quality	1.36 -	0.95 29.62%	0.64 33.15%	0.85 33.38%	0.86 1.28%	0.99 15.29%
intangibles to total assets	0 -	0	0	0	0	0
interest coverage					42.55 -	22.70 46.66%
interest debt per share				0.14 -	0.14 4.43%	0.00 99.39%
inventory turnover
invested capital				0.03 -	0.06 85.25%	0.33 480.32%
market cap	265.50M -	265.89M 0.15%	227.79M 14.33%	160.67M 29.47%	39.65M 75.32%	220.83B 556,841.52%
net current asset value	-14.15M -	-33.70M 138.17%	139.72M 514.56%	101.07M 27.66%	110.59M 9.42%	135.88M 22.87%
net debt to ebitda	3.11 -	1.53 50.95%	2.80 83.80%	0.36 87.29%	0.38 6.81%	-0.16 141.70%
net income per share	-0.46 -	-1.23 166.95%	-5.06 311.94%	-2.39 52.67%	-1.73 27.63%	-0.00 99.92%
operating cash flow per share	-0.62 -	-1.24 99.03%	-3.26 162.69%	-2.04 37.29%	-1.53 25.17%	-0.00 99.91%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets	-0.16 -	-0.39 142.81%	-0.33 15.10%	-0.46 38.50%	-0.47 2.97%	-0.35 24.64%
revenue per share
roe	0.50 -	0.56 11.67%	-0.35 163.02%	-0.52 46.18%	-0.55 6.89%	-0.51 8.20%
roic	1.39 -	0.59 57.49%	-0.36 160.39%	-0.49 36.25%	-0.52 7.63%	-0.40 23.51%
sales general and administrative to revenue
shareholders equity per share	-0.92 -	-2.19 139.07%	14.33 753.71%	4.64 67.62%	3.14 32.29%	0.00 99.91%
stock based compensation to revenue
tangible asset value	-13.88M -	-33.22M 139.42%	158.10M 575.94%	109.27M 30.89%	118.39M 8.35%	140.48M 18.65%
tangible book value per share	-0.92 -	-2.19 139.07%	14.33 753.73%	4.64 67.62%	3.14 32.41%	0.00 99.91%
working capital	40.88M -	44.22M 8.19%	141.01M 218.84%	103.71M 26.45%	116.68M 12.51%	181.56M 55.61%

All numbers in USD (except ratios and percentages)